| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |